Honghong Lu

Dr. Honghong Lu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
MWMian Wu
Mian Wu
XHXingna Hu
Xingna Hu
TLTing Lu
Ting Lu
CLChenxiao Liu
Chenxiao Liu
HLHonghong Lu
Honghong Lu
Objectives: To explore pro‐inflammatory cytokines status in the tear fluid of patients with hyperuricemia and gout and its association with uric acid level.Methods: A total of 58 control subjects, 58 hyperuricemia patients including 40 asymptomatic hyperuricemia and 18 gout participants were recruited in this study. For tear analysis, each patient's tears were collected using capillary action microcaps after stimulation. Tear uric acid levels were measured using chemiluminescence. Tear and serum interleukin‐1beta (IL‐1β) and tumor necrosis factor‐alpha (TNF‐α) levels were measured using enzyme‐linked immunosorbent assay. The correlation of serum and tear uric acid levels with IL‐1β and TNF‐α were determined.Results: Tear uric acid levels were significantly higher in hyperuricemia group (98.2 ± 51.5 vs. 42.7 ± 24.0 µmol/L, p < .001) than in controls group. IL‐1β concentrations were significantly higher in hyperuricemia eyes compared to control eyes (210.2 ± 113.9 vs. 142.6 ± 29.8 pg/mL, p < .001). Multiple linear regression analysis showed that tear uric acid levels were independently positively associated with tear IL‐1β concentrations (B = 0.192, p < .001). However, no significant correlations were found between serum or tear uric acid and TNF‐α level. Moreover, there were no statistically differences of tear IL‐1β and TNF‐α levels between the asymptomatic hyperuricemia and gout groups.Conclusions: Tear uric acid levels were higher in patients with hyperuricemia and gout than in controls. There was a significant positive correlation between tear uric acid value and tear IL‐1β level, implying an interaction between hyperuricemia and ocular inflammation responses.

14 October 2020 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
YZYun Zhao
Yun Zhao
SMSuxian Ma
Suxian Ma
XHXingna Hu
Xingna Hu
MFMin Feng
Min Feng
RXRong Xiang
Rong Xiang
HLHonghong Lu
Honghong Lu

21 November 2023 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
CLChenxiao Liu
Chenxiao Liu
XHXingna Hu
Xingna Hu
YZYun Zhao
Yun Zhao
AHAijie Huang
Aijie Huang
JCJiaqi Chen
Jiaqi Chen
HLHonghong Lu
Honghong Lu
The kidneys have a high level of Netrin-1 expression, which protects against some acute and chronic kidney disorders. However, it is yet unknown how Netrin-1 affects renal proximal tubule cells in diabetic nephropathy (DN) under pathological circumstances. Research has shown that autophagy protects the kidneys in animal models of renal disease. In this study, we looked at the probable autophagy regulation mechanism of Netrin-1 and its function in the pathogenesis of DN. We proved that in HK-2 cell, high blood sugar levels caused Netrin-1 to be downregulated, which then triggered the Akt/mTOR signaling pathway and enhanced cell death and actin cytoskeleton disruption. By adding Netrin-1 or an autophagy activator in vitro, these pathogenic alterations were reverted. Our results indicate that Netrin-1 stimulates autophagy by blocking the Akt/mTOR signaling pathway, which underlies high-glucose-induced malfunction of the renal proximal tubules. After HK-2 cells were incubated with Netrin-1 recombination protein and rapamycin under HG conditions for 24 h, the apoptosis was significantly reduced, as shown by the higher levels of Bcl-2, as well as lower levels of Bax and cleaved caspase-3 ( , Cohen’s , Glass’s , Hedges’ ). This study reveals that targeting Netrin-1-related signaling has therapeutic potential for DN and advances our knowledge of the processes operating in renal proximal tubules in DN.

20 February 2025 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
YZYun Zhao
Yun Zhao
TLTing Lu
Ting Lu
MWMian Wu
Mian Wu
XHXingna Hu
Xingna Hu
RXRong Xiang
Rong Xiang
HLHonghong Lu
Honghong Lu
Objective: Obesity and insulin resistance carry a high risk of progressing to type 2 diabetes mellitus. A lot of evidence has tightly associated insulin resistance with chronic inflammation. Besides, it has been reported that the activation of amphiregulin epidermal growth factor receptor pathways is involved in chronic inflammation. The aim of this study was to evaluate the relationship between insulin resistance and amphiregulin. Methods: Data from 203 volunteers were collected from November 2020 to June 2023 visiting the Affiliated Suzhou Hospital of Nanjing Medical University, Jiangsu, China. The serum levels of amphiregulin and diabetes-related parameters were measured in all participants. The correlation analysis and multiple stepwise regression of amphiregulin and some diabetes indicators were performed in all groups. Results: The concentrations of amphiregulin were 143.29, 163.29, 158.92, 171.89 and 155.03 pg/mL in the normal, obesity, nonobese diabetes, obese diabetes and obese diabetes after therapy groups (P < 0.01), respectively, and the homeostasis model assessment index were 1.6, 4.01, 3.93, 6.67 and 3.4, respectively (P < 0.01). Moreover, amphiregulin positively correlated with the homeostasis model assessment index in each separated group and the total sample (r = 0.644, P < 0.01). Meanwhile, the regression analysis showed a strong, positive association between amphiregulin and the homeostasis model assessment index (P < 0.01). More importantly, this correlation remained after obese diabetes patients were treated with drugs to relieve insulin resistance. Conclusion: Amphiregulin is upregulated in obese individuals than in normal size people, whether diabetic or not, and positively correlates with the homeostasis model assessment index, suggesting early signs of insulin resistance and abnormal glucose metabolism.